Developer docs
API playgroundTry for free, no card

Search company profiles

Clariness

Full company profile

uuid0008lp5

Namestring
Clariness
Legal namestring
Clariness GmbH
Websiteurl
clariness.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Clariness is a privately held clinical trial patient recruitment and enrollment intelligence company founded in 2005 in Hamburg, Germany. The company operates an integrated enrollment ecosystem called the Clariness Hub, which combines three platforms: ClinSight for enrollment feasibility benchmarking and protocol burden scoring, ClinLife for global patient engagement and recruitment across 60+ countries and 35+ languages, and ClinStudio for collaborative development and deployment of study materials. Clariness has supported more than 2,500 studies over 20 years, randomized over 42,000 patients across 400+ indications, and partners with 12,500+ research sites and 300+ patient organizations.

The company serves four primary customer segments: pharmaceutical sponsors (including 22 of 25 leading sponsors), contract research organizations (CROs), research sites, and patients. Revenue is generated through multi-year outcome-based contracts with three commercial components — setup and systems, outreach and media, and performance delivery — with reported forecast cost accuracy of approximately 90% for patient referral, consent, and randomization. Go-to-market combines direct enterprise sales to sponsors and CROs, CRO channel partnerships (more than 50% of studies are rescue engagements), and a patient- and community-led acquisition motion through the 15M+ ClinLife community. Distribution is supported by offices in Princeton, Austin, Hamburg, Berlin, London, Baar, Cape Town, Shanghai, and Belgrade.

Following its January 2026 merger with SubjectWell, Clariness operates as a combined entity under CEO Jim Corrigan, integrating SubjectWell's US patient infrastructure with Clariness' EMEA and APAC enrollment ecosystem. The leadership team includes a President and Chief Commercial Officer, Chief Operating and Compliance Officer, Chief Technology Officer, Chief Financial Officer, and Chief Scientific Officer, supported by an Enrollment Enablement Team of more than 80 specialists covering 35+ languages. Reported customer satisfaction metrics are 9.4/10 (client), 8.8/10 (patient), and 8/10 (site), with documented performance upside such as 245% of randomization target in a COVID-19 study and 166% in an Alzheimer's study.

Short descriptiontext

Clariness is a private clinical trial patient recruitment company operating the Clariness Hub, integrating ClinSight enrollment intelligence, ClinLife patient engagement, and ClinStudio creative platforms to deliver outcome-based enrollment services to pharmaceutical sponsors, CROs, and research sites across 60+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient recruitment services, clinical trial enrollment, enrollment feasibility analysis, patient engagement platform, clinical study recruitment
Industry2 codes
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code1 code
  • Professional, Scientific, and Technical Services541
SIC code1 code
  • Services-Health Services8000
Product category
Clinical Trial Patient Recruitment Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Outcome-Based / Performance Pricing
TypeUsage Based
Description

Full commitment to outcome-based pricing with balanced commercial models across three key areas: setup and systems, outreach and media, and performance delivery with full transparency of investment against each stage of enrollment funnel projections. Approximately 90% cost accuracy of forecasted patient referral, consent, and randomization costs.

clariness.com
2Setup and Systems Fees
TypeSubscription Recurring
Description

Setup fees for platform access, systems configuration, and study onboarding including site workflow calibration and onboarding in local language.

clariness.com
3Outreach and Media Services
TypeProfessional Services
Description

Digital patient recruitment campaigns across paid social including Meta, search, display, patient communities, condition-specific portals, and partner networks. Channel mix is indication- and geography-led, not platform-led.

clariness.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure
Pricing details1 tier
1Custom outcome-based pricing aligned to study requirements and enrollment goals
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Performance-based commercial models with setup, media, and delivery components. Forecast accuracy of approximately 90% for patient referral, consent, and randomization costs.

clariness.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clariness provides end-to-end patient recruitment and enrollment services for clinical trials, supporting pharmaceutical sponsors, contract research organizations (CROs), and research sites globally. Its offering spans enrollment feasibility planning, protocol-specific patient pre-screening, digital patient outreach campaigns, creative production of study materials, and engagement and retention support, delivered through an integrated technology ecosystem (the Clariness Hub) that connects ClinSight enrollment intelligence, ClinLife global patient platform, and ClinStudio creative platform across 60+ countries and 35+ languages.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 11 values shown
  • 42,000+ patients randomized across 400+ indications globally
+10 more records
Product overview1 text field

Clariness offers a unified platform-plus-modules architecture called the Clariness Hub, which integrates three core technology platforms. ClinSight serves as the enrollment intelligence platform for feasibility benchmarking and protocol assessment. ClinLife acts as the global patient recruitment engine connecting patients, sites, and sponsors across 60+ countries. ClinStudio provides the creative platform for developing and managing study materials. Together, these platforms support the complete clinical trial enrollment lifecycle from feasibility planning through patient recruitment to engagement and retention.

Product and service7 records
1Clariness Hub
CategoryPlatform
Description

Integrated enrollment ecosystem platform that connects enrollment feasibility, patient recruitment, and creative deployment platforms in one workspace, providing sponsors unified access to ClinSight, ClinLife, and ClinStudio capabilities.

2ClinLife
CategoryPlatform
Description

Global patient engagement platform that powers patient recruitment, site conversion, and study reporting, connecting patients, sites, and sponsors through a seamless enrollment journey across 60+ countries and 35+ languages, serving 12,500+ sites and millions of patients.

3ClinSight
CategoryPlatform
Description

Enrollment intelligence platform that combines proprietary recruitment data, external real-world datasets, and statistical protocol benchmarking to help teams validate recruitment timelines, quantify protocol burden, and optimize country and site strategies for enrollment acceleration.

4ClinStudio
CategoryPlatform
Description

Creative platform that streamlines the design, development, and deployment of study materials and patient engagement content, with version control, EC/IRB approval tracking, print/shipping management, and digital asset management capabilities that increase production efficiencies by 30%.

5Patient Recruitment Services
CategoryService
Description

End-to-end patient recruitment service for clinical trials that delivers accurate funnel strategies, protocol-specific pre-screening, digital outreach, and enrollment support across 400+ indications in 60+ countries, achieving >80% patient, site, and client satisfaction scores.

6Enrollment Feasibility Services
CategoryService
Description

Enrollment feasibility service that scientifically removes uncertainty from enrollment planning through enrollment benchmarking, patient feasibility analysis, patient and site surveys, and patient interviews and panels, with the goal of accelerating time-to-market for clinical trials.

7Engagement & Retention Services
CategoryService
Description

Engagement and retention service that delivers materials, content, and experiences designed to keep patients engaged and sites progressing study objectives, with creatives co-created with 3M patients and delivered for 175+ indications in 35+ languages.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierKeyTypeStrategic or Co-development PartnerAnnounced on2023-06-28
Description

Fortrea and Clariness collaborated on a webinar discussing how patient-reported data can save millions in enrollment delays. The partnership explored how patient insights can improve enrollment rates by helping sponsors identify and reach right patient populations.

Strategic tierKeyTypeGTM or Marketing Partner
Description

Meta is one of Clariness' key partners for digital patient outreach. Clariness operates one of the largest digital patient outreach networks combining paid social including Meta, search, display, patient communities, condition-specific portals, ClinLife organic traffic, and partner networks. Meta represents a portion of channel mix but Clariness purposefully diversifies with many other partners.

3300+ Patient Organizations & Research Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clariness has strategic partnerships with 300+ patient organizations and research partners extending patient reach. These partnerships enable access to patient communities, support patient-centered research initiatives, and facilitate recruitment across diverse patient populations globally.

clariness.com
4100+ Affiliate Partner Network
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Clariness leverages an affiliate partner network of 100+ partners across 20+ countries for digital patient outreach. This diversified channel mix ensures optimal channel strategy based on indication, geography, and patient population rather than platform-led approach.

clariness.com
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Clariness supported Bayer's 360 study review process with patient insights and data. This collaboration demonstrates the company's ability to provide actionable patient insights that inform study design and recruitment strategies.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Clariness gathered insights from 6,000 patients across nine countries with Regeneron to increase clinical trial diversity. This partnership contributed to published research on breaking down study barriers.

7JMIR Publications
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clariness models validated through peer-reviewed publications in JMIR Mental Health and other scientific journals. Published research on data-driven channel selection, reaching undiagnosed patients, and virtual recruitment performance.

clariness.com
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Full-service biopharmaceutical solutions organization with clinical and patient recruitment services; comparable in serving pharma sponsors with enrollment support across geographies.

TypeDirect peer
Description

US-based patient recruitment platform that merged with Clariness in January 2026; directly overlaps in patient recruitment for clinical trials with complementary geographic and patient-access strengths.

TypeBroad incumbent
Description

Largest global CRO offering patient recruitment as part of broad clinical and commercial services; competes with Clariness on global trial recruitment engagements, particularly with top-25 pharma sponsors.

TypeBroad incumbent
Description

Major global CRO with dedicated patient recruitment and feasibility capabilities; competes with Clariness for outsourced trial enrollment work from large pharma.

TypeBroad incumbent
Description

Large global CRO offering patient recruitment and feasibility services alongside clinical operations; competes for enterprise recruitment engagements from top pharma.

TypeBroad incumbent
Description

Mid-to-large CRO with full-service clinical operations including site and patient recruitment support; competes with Clariness for global Phase II–III trial work.

TypeEmerging player
Description

Decentralized clinical trial platform with patient recruitment capabilities; competes with Clariness on digitally enabled trial enrollment, particularly for sponsors adopting DCT models.

8Deep 6 AI
TypeEmerging player
Description

AI-native patient identification platform using EHR data mining for trial recruitment; represents a technology-led competitive threat to traditional multi-channel recruitment players like Clariness.

TypeEmerging player
Description

Tech-enabled patient recruitment platform focused on matching patients to clinical trials using provider and community networks; overlaps with Clariness' sponsor-facing recruitment offering.

10Antidote (formerly TrialReach)
TypeEmerging player
Description

Digital patient recruitment company using technology-driven matching and outreach to accelerate trial enrollment; comparable to Clariness' patient-centric digital recruitment approach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clariness

Clinical Trial Patient Recruitment Servicesclariness.com

Clariness is a private clinical trial patient recruitment company operating the Clariness Hub, integrating ClinSight enrollment intelligence, ClinLife patient engagement, and ClinStudio creative platforms to deliver outcome-based enrollment services to pharmaceutical sponsors, CROs, and research sites across 60+ countries.

What Clariness does

Clariness is a privately held clinical trial patient recruitment and enrollment intelligence company founded in 2005 in Hamburg, Germany. The company operates an integrated enrollment ecosystem called the Clariness Hub, which combines three platforms: ClinSight for enrollment feasibility benchmarking and protocol burden scoring, ClinLife for global patient engagement and recruitment across 60+ countries and 35+ languages, and ClinStudio for collaborative development and deployment of study materials. Clariness has supported more than 2,500 studies over 20 years, randomized over 42,000 patients across 400+ indications, and partners with 12,500+ research sites and 300+ patient organizations.

The company serves four primary customer segments: pharmaceutical sponsors (including 22 of 25 leading sponsors), contract research organizations (CROs), research sites, and patients. Revenue is generated through multi-year outcome-based contracts with three commercial components — setup and systems, outreach and media, and performance delivery — with reported forecast cost accuracy of approximately 90% for patient referral, consent, and randomization. Go-to-market combines direct enterprise sales to sponsors and CROs, CRO channel partnerships (more than 50% of studies are rescue engagements), and a patient- and community-led acquisition motion through the 15M+ ClinLife community. Distribution is supported by offices in Princeton, Austin, Hamburg, Berlin, London, Baar, Cape Town, Shanghai, and Belgrade.

Following its January 2026 merger with SubjectWell, Clariness operates as a combined entity under CEO Jim Corrigan, integrating SubjectWell's US patient infrastructure with Clariness' EMEA and APAC enrollment ecosystem. The leadership team includes a President and Chief Commercial Officer, Chief Operating and Compliance Officer, Chief Technology Officer, Chief Financial Officer, and Chief Scientific Officer, supported by an Enrollment Enablement Team of more than 80 specialists covering 35+ languages. Reported customer satisfaction metrics are 9.4/10 (client), 8.8/10 (patient), and 8/10 (site), with documented performance upside such as 245% of randomization target in a COVID-19 study and 166% in an Alzheimer's study.

Clariness firmographics

Firmographics
Name
Clariness
Legal name
Clariness GmbH
Website
https://clariness.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
Clariness is a private clinical trial patient recruitment company operating the Clariness Hub, integrating ClinSight enrollment intelligence, ClinLife patient engagement, and ClinStudio creative platforms to deliver outcome-based enrollment services to pharmaceutical sponsors, CROs, and research sites across 60+ countries.
Ownership category
akta.pro rank

Clariness industry classification

Industry
Product category
Clinical Trial Patient Recruitment Services
NAICS
Professional, Scientific, and Technical Services (541)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Patient recruitment services
  • Clinical trial enrollment
  • Enrollment feasibility analysis
  • Patient engagement platform
  • Clinical study recruitment

Where Clariness is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices9 records

Markets served

Clariness business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Outcome-Based / Performance Pricing: Full commitment to outcome-based pricing with balanced commercial models across three key areas: setup and systems, outreach and media, and performance delivery with full transparency of investment against each stage of enrollment funnel projections. Approximately 90% cost accuracy of forecasted patient referral, consent, and randomization costs.
  2. Setup and Systems Fees: Setup fees for platform access, systems configuration, and study onboarding including site workflow calibration and onboarding in local language.
  3. Outreach and Media Services: Digital patient recruitment campaigns across paid social including Meta, search, display, patient communities, condition-specific portals, and partner networks. Channel mix is indication- and geography-led, not platform-led.

Pricing tiers

ModelBillingPrice
Outcome Based/ PerformanceMulti-year contractCustom outcome-based pricing aligned to study requirements and enrollment goals

Go-to-market motion4 records

Distribution channels3 records

Marketing channels10 records

Clariness product offering

Product offering

Core offering

Clariness provides end-to-end patient recruitment and enrollment services for clinical trials, supporting pharmaceutical sponsors, contract research organizations (CROs), and research sites globally. Its offering spans enrollment feasibility planning, protocol-specific patient pre-screening, digital patient outreach campaigns, creative production of study materials, and engagement and retention support, delivered through an integrated technology ecosystem (the Clariness Hub) that connects ClinSight enrollment intelligence, ClinLife global patient platform, and ClinStudio creative platform across 60+ countries and 35+ languages.

Product overview

Clariness offers a unified platform-plus-modules architecture called the Clariness Hub, which integrates three core technology platforms. ClinSight serves as the enrollment intelligence platform for feasibility benchmarking and protocol assessment. ClinLife acts as the global patient recruitment engine connecting patients, sites, and sponsors across 60+ countries. ClinStudio provides the creative platform for developing and managing study materials. Together, these platforms support the complete clinical trial enrollment lifecycle from feasibility planning through patient recruitment to engagement and retention.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clariness Hub Integrated enrollment ecosystem platform that connects enrollment feasibility, patient recruitment, and creative deployment platforms in one workspace, providing sponsors unified access to ClinSight, ClinLife, and ClinStudio capabilities.
  • ClinLife Global patient engagement platform that powers patient recruitment, site conversion, and study reporting, connecting patients, sites, and sponsors through a seamless enrollment journey across 60+ countries and 35+ languages, serving 12,500+ sites and millions of patients.
  • ClinSight Enrollment intelligence platform that combines proprietary recruitment data, external real-world datasets, and statistical protocol benchmarking to help teams validate recruitment timelines, quantify protocol burden, and optimize country and site strategies for enrollment acceleration.
  • ClinStudio Creative platform that streamlines the design, development, and deployment of study materials and patient engagement content, with version control, EC/IRB approval tracking, print/shipping management, and digital asset management capabilities that increase production efficiencies by 30%.
  • Patient Recruitment Services End-to-end patient recruitment service for clinical trials that delivers accurate funnel strategies, protocol-specific pre-screening, digital outreach, and enrollment support across 400+ indications in 60+ countries, achieving >80% patient, site, and client satisfaction scores.
  • Enrollment Feasibility Services Enrollment feasibility service that scientifically removes uncertainty from enrollment planning through enrollment benchmarking, patient feasibility analysis, patient and site surveys, and patient interviews and panels, with the goal of accelerating time-to-market for clinical trials.
  • Engagement & Retention Services Engagement and retention service that delivers materials, content, and experiences designed to keep patients engaged and sites progressing study objectives, with creatives co-created with 3M patients and delivered for 175+ indications in 35+ languages.

Quantifiable outcome

  • 42,000+ patients randomized across 400+ indications globally
  • +10 more outcomes

Companies that use Clariness

Customer profile

Named customers7 records

Segments4 records

Ideal customer profiles3 records

Clariness technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Clariness partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered key, core, supporting and flagship.

  • FortreakeyStrategic or Co-development Partner · 28 June 2023Fortrea and Clariness collaborated on a webinar discussing how patient-reported data can save millions in enrollment delays. The partnership explored how patient insights can improve enrollment rates by helping sponsors identify and reach right patient populations.
  • MetakeyGTM or Marketing PartnerMeta is one of Clariness' key partners for digital patient outreach. Clariness operates one of the largest digital patient outreach networks combining paid social including Meta, search, display, patient communities, condition-specific portals, ClinLife organic traffic, and partner networks. Meta represents a portion of channel mix but Clariness purposefully diversifies with many other partners.
  • 300+ Patient Organizations & Research PartnerscoreStrategic or Co-development PartnerClariness has strategic partnerships with 300+ patient organizations and research partners extending patient reach. These partnerships enable access to patient communities, support patient-centered research initiatives, and facilitate recruitment across diverse patient populations globally.
  • 100+ Affiliate Partner NetworksupportingChannel Partner/ Reseller/ DistributorClariness leverages an affiliate partner network of 100+ partners across 20+ countries for digital patient outreach. This diversified channel mix ensures optimal channel strategy based on indication, geography, and patient population rather than platform-led approach.
  • BayerflagshipStrategic or Co-development PartnerClariness supported Bayer's 360 study review process with patient insights and data. This collaboration demonstrates the company's ability to provide actionable patient insights that inform study design and recruitment strategies.
  • RegeneronflagshipStrategic or Co-development PartnerClariness gathered insights from 6,000 patients across nine countries with Regeneron to increase clinical trial diversity. This partnership contributed to published research on breaking down study barriers.
  • JMIR PublicationssupportingStrategic or Co-development PartnerClariness models validated through peer-reviewed publications in JMIR Mental Health and other scientific journals. Published research on data-driven channel selection, reaching undiagnosed patients, and virtual recruitment performance.

Scale indicators14 records

Recent moves10 records

Expansion highlights6 records

Clariness competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Full-service biopharmaceutical solutions organization with clinical and patient recruitment services; comparable in serving pharma sponsors with enrollment support across geographies.
  • IQVIA: Largest global CRO offering patient recruitment as part of broad clinical and commercial services; competes with Clariness on global trial recruitment engagements, particularly with top-25 pharma sponsors.
  • ICON plc: Major global CRO with dedicated patient recruitment and feasibility capabilities; competes with Clariness for outsourced trial enrollment work from large pharma.
  • Parexel: Large global CRO offering patient recruitment and feasibility services alongside clinical operations; competes for enterprise recruitment engagements from top pharma.
  • Medpace: Mid-to-large CRO with full-service clinical operations including site and patient recruitment support; competes with Clariness for global Phase II–III trial work.

Direct peers

  • SubjectWell: US-based patient recruitment platform that merged with Clariness in January 2026; directly overlaps in patient recruitment for clinical trials with complementary geographic and patient-access strengths.

Emerging players

  • Curebase: Decentralized clinical trial platform with patient recruitment capabilities; competes with Clariness on digitally enabled trial enrollment, particularly for sponsors adopting DCT models.
  • Deep 6 AI: AI-native patient identification platform using EHR data mining for trial recruitment; represents a technology-led competitive threat to traditional multi-channel recruitment players like Clariness.
  • Trial Library: Tech-enabled patient recruitment platform focused on matching patients to clinical trials using provider and community networks; overlaps with Clariness' sponsor-facing recruitment offering.
  • Antidote (formerly TrialReach): Digital patient recruitment company using technology-driven matching and outreach to accelerate trial enrollment; comparable to Clariness' patient-centric digital recruitment approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Clariness social profiles

Digital presence

Clariness compliance and trust

Trust signal

Compliance1 record

Clariness financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clariness leadership team

Management profile

Number of profiles

Profiles9 records

Clariness subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Clariness funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clariness M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clariness

What does Clariness do?

Clariness provides end-to-end patient recruitment and enrollment services for clinical trials, supporting pharmaceutical sponsors, contract research organizations (CROs), and research sites globally. Its offering spans enrollment feasibility planning, protocol-specific patient pre-screening, digital patient outreach campaigns, creative production of study materials, and engagement and retention support, delivered through an integrated technology ecosystem (the Clariness Hub) that connects ClinSight enrollment intelligence, ClinLife global patient platform, and ClinStudio creative platform across 60+ countries and 35+ languages.

Is Clariness a public or private company?

Clariness is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Clariness founded?

Clariness was founded in 2005. It employs 101 to 250 people.

Where is Clariness based?

Clariness is headquartered in Hamburg, Germany, in the Europe region.

How does Clariness make money?

Three revenue lines are on record. Outcome-Based / Performance Pricing is the primary driver. The others are setup and Systems Fees and outreach and Media Services.

Who are Clariness's main competitors?

Broad incumbents on record are Syneos Health, IQVIA, ICON plc, Parexel and Medpace. SubjectWell is listed as a direct peer. Emerging players are Curebase, Deep 6 AI, Trial Library and Antidote (formerly TrialReach).

Does Clariness have an API?

No public API is recorded for Clariness.

What industry is Clariness in?

Clariness's product category is Clinical Trial Patient Recruitment Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AijournAI in Clinical Trial Recruitment: Why the Future Is Human-First, AI-EnhancedClariness is implementing AI in its Omni-Channel Contact Center to automate intake triage and draft responses, freeing staff for participant engagement. The company argues AI cannot replace human judgment, empathy, and trust in recruitment, and will continue to support human expertise.AijournClariness Announces Jim Corrigan as CEO to Lead Next Phase of GrowthClariness, backed by WindRose Health Investors, announced Jim Corrigan as its new CEO and unveiled an integrated executive leadership team following the merger with SubjectWell. Corrigan brings 20+ years of experience as a three-time CEO with expertise in scaling high-growth companies and the clinical development lifecycle. The company stated it aims to leverage this leadership structure to advance its position as a global leader in patient recruitment and retention, improving trial performance and expanding access to clinical research worldwide.PR NewswireClariness Announces Jim Corrigan as CEO to Lead Next Phase of GrowthClariness announced Jim Corrigan as its new CEO and unveiled an integrated executive leadership team following the company's merger with SubjectWell, positioning itself for accelerated growth in the patient recruitment and retention space. Corrigan brings over 20 years of experience as a three-time CEO with expertise in scaling innovative healthcare companies and leading organizations through integration and growth. The company, backed by WindRose Health Investors, aims to leverage its combined technology-enabled solutions, scientific rigor, and operational excellence to deliver more predictable and powerful clinical trial outcomes for sponsors, CROs, and research sites worldwide.Pulse 2.0Clariness And SubjectWell Merge To Form Full-Service Patient Recruitment PlatformClariness and SubjectWell have announced a merger to form one of the largest global full-service patient recruitment platforms for clinical trials, with the transaction led by private equity firm WindRose Health Investors. The combined organization, operating under the Clariness name, will support clinical trials across more than 60 countries, partnering with over 10,000 research sites and having delivered more than 42,000 randomizations. The merger aims to accelerate clinical trial timelines and improve recruitment performance by integrating technology, patient databases, and marketing capabilities under a unified platform.citybizFairmount Partners Advises Clariness on its Merger with SubjectWell to Form Global, Full-Service Patient Recruitment PlatformClariness and SubjectWell announced their merger to form one of the largest global full-service patient recruitment platforms for clinical trials, with the combined entity operating under the Clariness name. The transaction was led by WindRose Health Investors, which previously acquired SubjectWell in April 2024. The merged company will support clinical trials in over 60 countries, having delivered 42,000+ randomizations across 400+ indications and partnered with 10,000+ research sites globally.PR NewswireClariness and SubjectWell Merge to Form Global, Full-Service Patient Recruitment PlatformClariness and SubjectWell announced their merger to form a global patient recruitment platform for clinical trials, with the transaction led by private equity firm WindRose Health Investors. The combined entity will operate under the Clariness name and claims to support clinical trials across 60+ countries, having delivered 42,000+ randomizations and partnered with 10,000+ research sites globally. The merged company aims to set industry standards in patient recruitment while accelerating clinical research and expanding patient access to clinical trials worldwide.ClarinessPatient Recruitment Clinical TrialsClariness highlights that 80% of clinical trials fail due to insufficient patient recruitment and outlines innovative strategies to improve enrollment rates, such as using digital platforms and AI-driven analytics. The company promotes its ClinLife platform and case study with Boehringer Ingelheim to demonstrate how targeted recruitment efforts can successfully meet study targets.Intelegain5 Real-World Project Risk Management Case Studies You Should KnowThe article presents five case studies illustrating project risk management in diverse sectors, including Clariness GmbH's CRM transformation, the Gordie Howe International Bridge construction, Fujitsu's training program overhaul, Vodafone's global network migration, and the Fehmarnbelt tunnel infrastructure project. It highlights that effective risk management is critical for success, noting the global market size reached USD 13.5 billion in 2024 with projections to reach USD 38.9 billion by 2033. The piece emphasizes how structured planning, assessment, and control mechanisms help mitigate operational surprises and financial losses across complex initiatives.Roots AnalysisTop 10 Clinical Trial Patient Recruitment Service ProvidersRoots Analysis published a report identifying ten leading clinical trial patient recruitment service providers, including BBK Worldwide, Clariness, and CMIC. The article highlights that these firms utilize advanced technologies like social media, Electronic Health Records, and proprietary platforms to address the high costs and delays associated with patient enrollment in drug development.